The transcription factor FOXL2 in ovarian function and dysfunction.

Area of Science:

• Genetics
• Developmental Biology
• Ophthalmology
• Reproductive Endocrinology

Background:

• Blepharophimosis Ptosis Epicanthus-inversus Syndrome (BPES) is an autosomal dominant genetic disorder.
• BPES is characterized by complex eyelid malformations and is frequently associated with premature ovarian failure (POF).
• The syndrome is primarily caused by mutations in the FOXL2 gene, which encodes a crucial forkhead transcription factor.

Purpose of the Study:

• To review the current understanding of Blepharophimosis Ptosis Epicanthus-inversus Syndrome (BPES) and its genetic basis.
• To explore the role of the FOXL2 gene in the pathogenesis of BPES and premature ovarian failure (POF).
• To highlight the importance of studying FOXL2 gene regulation and targets for potential therapeutic development.

Main Methods:

• Review of existing literature on FOXL2 gene mutations and their correlation with BPES phenotypes.
• Analysis of data from mouse knock-out models that recapitulate BPES and POF.
• Discussion of the expression patterns of FOXL2 in relevant tissues (eyelids and ovaries).

Main Results:

• Over one hundred mutations in the FOXL2 gene have been identified in patients with BPES.
• FOXL2 is expressed in developing eyelids and ovaries, consistent with the observed phenotype.
• Mouse models confirm that loss-of-function mutations in FOXL2 lead to BPES and POF, while hypomorphic mutations may cause BPES without ovarian issues, though exceptions exist.

Conclusions:

• Mutations in the FOXL2 gene are the primary cause of BPES and associated POF.
• Understanding the genotype-phenotype correlations and exceptions is crucial for predicting disease outcomes.
• Further research into the normal regulation of FOXL2 and its downstream targets is essential for developing future therapeutic strategies.